Subscribe
shutterstock_1528056221_jhvephoto
JHVEphoto / Shutterstock.com
12 October 2023Big PharmaMarisa Woutersen

Medtronic’s $738m deal with insulin maker at risk

Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Americas
Roche accuses competitor of infringing diabetes patent
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Americas
Roche accuses competitor of infringing diabetes patent
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.

More on this story

Americas
Swiss big pharma settles patent dispute with Insulet
12 July 2022   The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.
Americas
Roche accuses competitor of infringing diabetes patent
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner